Status:
COMPLETED
Effect of Metabolic Therapy in Patients With Chronic Ischemic Heart Disease
Lead Sponsor:
IRCCS San Raffaele
Conditions:
Coronary Artery Disease
Type II Diabetes Mellitus
Eligibility:
All Genders
18-85 years
Phase:
PHASE4
Brief Summary
Patients with coronary artery disease have an abnormal cardiac metabolism. The hypothesis of this study is that shifting cardiac metabolism from free fatty acids to glucose will improve myocardial isc...
Detailed Description
The present study will evaluate the effect of free fatty acid inhibition with Trimetazidine on silent myocardial ischemia and total ischemic burden in coronary artery disease patients with type II dia...
Eligibility Criteria
Inclusion
- coronary artery disease type II diabetes mellitus -
Exclusion
- unstable coronary artery syndromes impaired liver and kidney function
- \-
Key Trial Info
Start Date :
February 1 1999
Trial Type :
INTERVENTIONAL
End Date :
October 1 2003
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT00282360
Start Date
February 1 1999
End Date
October 1 2003
Last Update
January 26 2006
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.